Literature DB >> 21475418

Current status of alpha-fetoprotein testing.

Morris Sherman1.   

Abstract

Entities:  

Year:  2011        PMID： 21475418      PMCID： PMC3061015     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  The resurrection of alphafetoprotein.

Authors:  Morris Sherman
Journal:  J Hepatol       Date:  2010-03-15       Impact factor: 25.083

2.  Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.

Authors:  Masakuni Tateyama; Hiroshi Yatsuhashi; Naota Taura; Yasuhide Motoyoshi; Shinya Nagaoka; Kenji Yanagi; Seigo Abiru; Koji Yano; Atsumasa Komori; Kiyoshi Migita; Minoru Nakamura; Hiroyasu Nagahama; Yutaka Sasaki; Yuzo Miyakawa; Hiromi Ishibashi
Journal:  J Gastroenterol       Date:  2010-08-14       Impact factor: 7.527

3.  Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Anna S Lok; Richard K Sterling; James E Everhart; Elizabeth C Wright; John C Hoefs; Adrian M Di Bisceglie; Timothy R Morgan; Hae-Young Kim; William M Lee; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Gastroenterology       Date:  2009-10-20       Impact factor: 22.682

4.  Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.

Authors:  Richard K Sterling; Lennox Jeffers; Fredric Gordon; Alan P Venook; K Rajender Reddy; Shinji Satomura; Futoshi Kanke; Myron E Schwartz; Morris Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-17       Impact factor: 11.382

5.  Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.

Authors:  Richard K Sterling; Lennox Jeffers; Fredric Gordon; Morris Sherman; Alan P Venook; K Rajender Reddy; Shinji Satomura; Myron E Schwartz
Journal:  Am J Gastroenterol       Date:  2007-07-07       Impact factor: 10.864
  5 in total
  4 in total

1.  Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.

Authors:  Roniel Cabrera; Asem I Fitian; Miguel Ararat; Yiling Xu; Todd Brusko; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Oncol Lett       Date:  2012-07-26       Impact factor: 2.967

Review 2.  Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?

Authors:  Edoardo G Giannini; Alessandro Cucchetti; Virginia Erroi; Francesca Garuti; Federica Odaldi; Franco Trevisani
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 3.  Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.

Authors:  Isidoro Di Carlo; Maurizio Mannino; Adriana Toro; Annalisa Ardiri; Antonio Galia; Giovanni Cappello; Gaetano Bertino
Journal:  World J Surg Oncol       Date:  2012-05-06       Impact factor: 2.754

4.  Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.

Authors:  Daniela Manuc; Carmen Monica Preda; Irina Sandra; Cristian Baicus; Razvan Cerban; Ileana Constantinescu; Andrei Ovidiu Olteanu; Cosmin Alexandru Ciora; Teodora Manuc; Daniela Elena Chiriac; Andreea Elena Chifulescu; Mircea Diculescu; Cristian Tieranu; Lucian Negreanu; Gabriela Oprea-Calin; Mircea Manuc
Journal:  J Med Life       Date:  2020 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.